Piperidine-ether based hNK1 antagonists 1: Determination of the relative and absolute stereochemical requirements
- 1 November 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (21) , 2545-2550
- https://doi.org/10.1016/s0960-894x(01)80280-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Synthesis of (±)-CP-99994: A highly potent substance P antagonistTetrahedron Letters, 1993
- Quinuclidine based NK-1 antagonists 2: determination of the absolute stereochemical requirementsBioorganic & Medicinal Chemistry Letters, 1993
- Discovery of a potent substance P antagonist: recognition of the key molecular determinantJournal of Medicinal Chemistry, 1992
- The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine as a novel, nonpeptide substance P antagonistJournal of Medicinal Chemistry, 1992
- Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraineTrends in Pharmacological Sciences, 1992
- A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) ReceptorScience, 1991
- Substance P primes human neutrophil activation: A mechanism for neurological regulation of inflammationBiochemical and Biophysical Research Communications, 1989
- Optically active N-protected .alpha.-amino aldehydes in organic synthesisChemical Reviews, 1989
- Effect of Neuropeptides on Production of Inflammatory Cytokines by Human MonocytesScience, 1988
- Substance P Activation of Rheumatoid Synoviocytes: Neural Pathway in Pathogenesis of ArthritisScience, 1987